Antidepressants. Professor Ian Jones May /WalesMentalHealth
|
|
- Hugh Little
- 5 years ago
- Views:
Transcription
1 Antidepressants Professor Ian Jones May 2017 /WalesMentalHealth
2 We identified pregnancies exposed to an antidepressant at some point during pregnancy. The rate of exposure increased from 0.2% in 1997 to 3.2% in 2010 Kjaersgaard et al, PLoS One. 2013
3 Problems with interpreting the data Case reports or small case series in past now studies of over 120,000 exposures and 102 papers published in 2015 Retrospective bias Data from non psychiatric disorders Increased vigilance for malformations in women taking medication Little information on the severity of malformation Residual confounding Depression, other medications, other risk factors
4 Questions 1. Are ADs associated with an increased risk of congenital malformations? 2. Are there long term implications of taking ADs? 3. What are the implications of stopping ADs in relation to pregnancy? 4. Do ADs impact on pregnancy outcomes? Yes, small effects on gestational age, birth weight and APGAR scores (Ross et al, JAMA Psychiatry, 2013) 5. Are ADs associated with neonatal complications? Yes, increased risk of postnatal adaption syndrome (PNAS) OR over 5 (Grigoriadis et al, 2013)
5 1) ADs and risk of congenital malformations Before 2005 no teratogenicity demonstrated for antidepressants (TCIs and SSRIs) BUT..Many studies small cohorts with insufficient power to detect anything other than very large effects 2006 two large studies reported x increased risk of cardiac defects with paroxetine exposure Cardiac defects 2/100 compared with 1/100 Many further studies in large numbers
6 Two Meta analyses Meta analysis of 16 (out of 115) studies: Fluoxetine (OR 1.14, 95% CI ) and paroxetine (OR 1.29, 95% CI ) associated with increased risk of major malformations Paroxetine associated with increased risk of cardiac malformations (OR 1.44, 95% CI ). Myles et al, ANZJP, 2013 Overall, antidepressants do not appear to be associated with an increased risk of congenital malformations, but statistical significance was found for cardiovascular malformations. Given that the RRs are marginal, they may be the result of uncontrolled confounders. Although the RRs were statistically significant, none reached clinically significant levels. Grigoriadis et al, 2013
7 Finish registry study The influence of confounding Major congenital abnormalities OR 1.24 ( ) Not significant when controlled for confounders OR 1.08 ( ) ADs less likely to be married, twice as likely to smoke, 20 times more likely to take other psychiatric medication, Fetal alcohol syndrome OR 9.6 ( ) Malm et al, Obstetrics and Gynecology, 2011
8 Further evidence of confounding 2.3 million births 36,772 SSRI exposures Cardiac defect adjusted OR =1.15 Sibling controls OR lower and not significant (0.92) Although the prevalence of septal defects and right ventricular outflow tract defects was higher in the exposed infants, the lack of an association in the sibling controlled analyses points against a teratogenic effect of these drugs Furu et al, BMJ, 2015
9 Do SSRI s increase risk of PPHN? 377 PPHN cases OR 6 1% N Eng J Med 2006;354:579-87
10 Further studies risk lower? Wichman et al 2007 case note review of 25,214 deliveries no association Kallen et al ,324 infants risk doubled 0.15% Andrade et al SSRI and 1104 controls case note review no association Reis and Kallen 2010 RR 2.56 for late exposure 0.2% Kieler et al, 2012 Scandinavian registries 1.6 million infants 30,000 SSRI exposures 0.3% (OR 2.1)
11 Largest study risk increase more modest JAMA. 2015;313(21): ,950 women who filled a prescription for antidepressants in late pregnancy (3.4%) Absolute risk small and risk appears more modest than suggested in previous studies OR = 1.51 ( ) Adjusted OR = 1.10 ( )
12 So...what has been shown Lack of consistency re malformations and drugs All commonly used SSRIs implicated plus clomipramine Multiple testing Residual confounding Not controlled for depression, obesity, drugs and alcohol, tobacco, use of folic acid, detection bias Absolute risk for any pregnant women low
13 2) Long term implications Croen et al, Arch Gen Psych, ASD kids 1507 controls 6.6% vs 3.3% at least 1 prescription or an antidepressant in the year prior to delivery OR 2.2 ( ) attrib risk 2.1% Highest risk in first trimester (OR 3.8, ) Numbers small 20 ASD kids with AD prescription Adequacy of controlling for confounders?
14 A number of further papers.
15 Two meta analyses Meta-analysis of 4 studies Pooled crude OR = 2.13 Adjusted OR = 1.81 two studies employing the same Danish data had conflicting results some signal exists.six out of eight reviewed articles confirm an association must still be cautiously interpreted
16 Long term impact Using a sibling design, we showed that prenatal antidepressant use was specifically associated with increased anxiety symptoms after adjusting for maternal familial factors and confounding by indication.
17 Possible Positive Impact of AD in pregnancy
18 AD exposed children do better than those with mothers with untreated depression
19 Impact of stopping AD Bad News!!! 201 euthymic women with history of MDD 68% recurrence in those who discontinued AD 26% recurrence in those who remained on AD History of severe mood disorder mean duration 15.4 years, 44% had 5 or more episodes Cohen et al., JAMA. 2006;295:
20 Or.being on AD s makes little difference Yonkers et al, Epidemiology, pregnant women with a history of major depression No effect of Antidepressant treatment Hazard Ratio 0.88 ( )
21 Summary and Conclusions Decisions about medication complex and difficult No longer can we say that we lack data on antidepressants in pregnancy small teratogenic risk still difficult to determine if due to drug or to confounding Emerging evidence of potential positive impacts Data on reproductive safety must be considered in light of full risk benefit analysis
22
23 Drugs used in the treatment of ADHD Methylphenidate (atomoxetine) A Danish register study found the rate increasing 5 to 533 per 100,000 person years between 2003 and 2010 (Haervig et al., 2014) Increased risk of miscarriage (Haervig et al., 2014) Further study no risk of miscarriage but low Apgar score at delivery (not seen in babies born to women with ADHD not on treatment) 186 exposures (Bro et al., 2015) Neonatal withdrawal symptoms
24 Conflicting data in animal and human studies Study in Mice The group treated with MPH presented significant external (polydactyly P < 0.01), skeletal (incomplete ossification of the skull P < 0.01) and visceral (dilated ventricles P < 0.05) malformations. Behavioural effects (motor activity, memory of habituation and anxiety) were not observed in both male and female offspring evaluated at postnatal days 22, 35 and 75. The results suggest that MPH is an embryotoxic and teratogenic drug Costa Gde A et al. Reprod Biomed Online. 2016;32(2):170 7 Study in Humans 382 methylphenidate exposed pregnancies No evidence of teratogenicity Diav Citrin et al. J Clin Psychiatry. 2016;77(9):
25 BAP Guidelines. There are limited data regarding the risks of in utero exposure to methylphenidate and very little regarding atomoxetine. Current data do not suggest a link between methylphenidate exposure and congenital malformations. Methylphenidate may be associated with an increased risk of miscarriage, but this may be a result of confounds related to the diagnosis of ADHD. Methylphenidate exposure in utero close to delivery may be associated with a neonatal syndrome with low Apgar scores and stimulant withdrawal syndrome. Risks associated with atomoxetine are undetermined. It is not known if it is appropriate to extrapolate from the data related to SNRIs and SSRIs.
Mental Health Series for Perinatal Prescribers. Pharmacotherapy for depression and anxiety
Mental Health Series for Perinatal Prescribers Pharmacotherapy for depression and anxiety Non-medication Treatments Psychosocial support Prenatal education, Doula support, La Leche League, Mom s groups,
More informationPsychiatry for GPs Perinatal Mental Health
Psychiatry for GPs Perinatal Mental Health Dr Michael Yousif, Consultant in Psychological Medicine, OUH NHSFT Perinatal mental health for GPs Diagnosing Prescribing 2 Perinatal mental health for GPs Is
More informationOUTCOMES OF INFANTS EXPOSED TO MULTIPLE ANTIDEPRESSANTS DURING PREGNANCY: RESULTS OF A COHORT STUDY
OUTCOMES OF INFANTS EXPOSED TO MULTIPLE ANTIDEPRESSANTS DURING PREGNANCY: RESULTS OF A COHORT STUDY A Einarson 1, J Choi 1, G Koren 1,2, TR Einarson 1,2 1 The Motherisk Program, The Hospital for Sick Children,
More informationPerinatal Mental Health: Prescribing Guidance for Trust Prescribers and GPs
Perinatal Mental Health: Prescribing Guidance for Trust Prescribers and GPs (Version 3 January 2015) Principal Author: Dr Jenny Cooke Consultant Psychiatrist, Brighton & Hove Perinatal Mental Health Service
More informationDepression PROTOCOL 3
PROTOCOL 3 Depression Kimberly Yonkers 1,2,3 1 Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA 2 Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University
More informationDisclosures. Objectives. Talk Overview 11/28/2016. Evidence-Based Approaches to Psychiatric Care during Pregnancy in the Age of Sensationalized Media
Evidence-Based Approaches to Psychiatric Care during Pregnancy in the Age of Sensationalized Media Disclosures Legal consultant to Astra Zeneca, Eli Lilly, Johnson and Johnson Research Support from NIMH,
More informationPsychotropic Medications in Pregnancy. Leanne Martin MD, MSc (Medicine), FRCPC Psychiatrist Cambridge Memorial Hospital
Psychotropic Medications in Pregnancy Leanne Martin MD, MSc (Medicine), FRCPC Psychiatrist Cambridge Memorial Hospital Psychotropic Medications in Pregnancy Dr. Leanne Martin Day in Psychiatry 2018 Declaration
More informationPost Partum Depression. Dr. Bev Young Department of Psychiatry, Mount Sinai Hospital
Post Partum Depression Dr. Bev Young Department of Psychiatry, Mount Sinai Hospital Outline of Presentation Postpartum Mood Disorders Postpartum Blues Postpartum Depression Postpartum Psychosis Meds during
More informationMaternal Mental Health:
Maternal Mental Health: Impact, Identification, and Intervention Ashley Blackmon Jones, MD Associate Professor of Clinical Psychiatry Adjunct Associate Professor of Clinical Obstetrics and Gynecology April
More informationDepression in Pregnancy
TREATING THE MOTHER PROTECTING THE UNBORN A MOTHERISK Educational Program The content of this program reflects the expression of a consensus on emerging clinical and scientific advances as of the date
More information7 th Annual ECMH Conference 2016 Alison Reminick, MD
Objectives MATERNAL DEPRESSION Director of Women s Reproductive Mental Health University California, San Diego Describe the effects of maternal depression on fetal and neonatal health Describe normal changes
More informationDepression and Antidepressant Medications during Pregnancy
Depression and Antidepressant Medications during Pregnancy Teri Pearlstein, MD Director, Women s Behavioral Medicine Women s Medicine Collaborative, Miriam Hospital Professor of Psychiatry and Human Behavior
More informationARTICLE. Neonate Characteristics After Maternal Use of Antidepressants in Late Pregnancy. 1-8 HAVE BEEN PUBlished
Neonate Characteristics After Maternal Use of Antidepressants in Late Pregnancy Bengt Källén, MD, PhD ARTICLE Background: Exposure to antidepressants during the third trimester of pregnancy has been associated
More informationPrenatal and Post Partum Depression is Not Just a Mood. This is Serious Stuff.
Prenatal and Post Partum Depression is Not Just a Mood. This is Serious Stuff. Deborah McMahan, MD Health Commissioner Prenatal and Infant Care Network November 28, 2016 Agenda Prevalence of mental illness
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Patorno E, Huybrechts KF, Bateman BT, et al. Lithium use in
More information11b). Does the use of folic acid preconceptually decrease the risk of foetal malformations in women with epilepsy?
updated 2012 Management of epilepsy in women of child bearing age Q11: 11a). In women with epilepsy, should antiepileptic therapy be prescribed as monotherapy or polytherapy to decrease the risk of fetal
More informationSupplementary Online Content
Supplementary Online Content Viktorin A, Uher R, Kolevzon A, Reichenberg A, Levine SZ, Sandin S. Association of antidepressant medication use during pregnancy with intellectual disability in offspring.
More informationBMJ Open. Pharmacology and therapeutics. Maternal medicine < OBSTETRICS, Depression & mood disorders < PSYCHIATRY, EPIDEMIOLOGY
Combined use of selective serotonin reuptake inhibitor and sedatives/hypnotics during pregnancy: Risk of relatively severe congenital malformations or cardiac defects. A register study Journal: Manuscript
More informationCourse and Treatment of Depression and Bipolar Illness during Pregnancy : Knowns and Unknowns
Course and Treatment of Depression and Bipolar Illness during Pregnancy : Knowns and Unknowns Lee S. Cohen, MD Director, Ammon-Pinizzotto Center for Women s Mental Health Massachusetts General Hospital
More informationReport Information from ProQuest
Report Information from ProQuest 17 May 2015 07:36 17 May 2015 ProQuest Table of contents 1. Antidepressants in pregnancy... 1 17 May 2015 ii ProQuest Document 1 of 1 Antidepressants in pregnancy Author:
More informationGSK Medicine: Study Number: Title: Rationale: Study Period: Objectives: Indication: Study Investigators/Centers: Data Source:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationPregnancy. General Principles of Prescribing in Pregnancy (The Maudsley, 12 th Edition)
Pregnancy General Principles of Prescribing in Pregnancy (The Maudsley, 12 th Edition) In all women of child bearing potential Always discuss the possibility of pregnancy; half of all pregnancies are unplanned
More informationPerinatal Mental Health: Prescribing Guidance for Trust Prescribers and GPs
Perinatal Mental Health: Prescribing Guidance for Trust Prescribers and GPs (Version 3 January 2018) Principal Authors: Dr Jenny Cooke Consultant Psychiatrist, Brighton & Hove Perinatal Mental Health Service
More informationMarijuana Use During Pregnancy and Breastfeeding Findings Summary
The Colorado Department of Public Health and Environment (CDPHE) was assigned the responsibility to appoint a panel of health care professionals with expertise in cannabinoid physiology to monitor the
More informationWhy do We Let Mothers Suffer?
Why do We Let Mothers Suffer? Comparing Exposure to Antidepressants vs Exposure to Illness in Perinatal Depression Sanjeev Bhatla,MDCM,CCFP,FCFP March 1, 2014 Faculty/Presenter Disclosure Faculty/Presenter:
More informationPostpartum Psychosis and Bipolar Disorder
Postpartum Psychosis and Bipolar Disorder Professor Ian Jones April 2016 www.ncmh.info @ncmh_wales 029 2074 4392 info@ncmh.info Bipolar Disorder DEPRESSION Low mood Loss of enjoyment MANIA Elevated mood
More informationCourse and Treatment of Psychiatric Disorder During Pregnancy: Lessons Learned over Two Decades
Course and Treatment of Psychiatric Disorder During Pregnancy: Lessons Learned over Two Decades Lee S. Cohen, MD Director, Ammon-Pinizzotto Center for Women s Mental Health Massachusetts General Hospital
More information2015 Updates: Psychopharmacology of Pregnant & Postpartum Women
2015 Updates: Psychopharmacology of Pregnant & Postpartum Women Judy A. Greene, M.D. Director, Women s Mental Health Director, Reproductive Psychiatry Fellowship Program Clinical Assistant Professor, NYU
More informationMother May I? Managing Mental Illness During Pregnancy: Focus on Antidepressants
Handout for the Neuroscience Education Institute (NEI) online activity: Mother May I? Managing Mental Illness During Pregnancy: Focus on Antidepressants Learning Objectives Evaluate the potential risks
More informationMedication management of anxiety & depression. Dr Katie Simpson GP Mental health lead East Berks CCG
Medication management of anxiety & depression Dr Katie impson GP Mental health lead East Berks CCG NICE guidelines for Anxiety tepped Care RIs and NRIs in Anxiety disorders RI ertraline Citalopram Fluoxetine
More informationMaternal and Fetal Outcomes After Lamotrigine Use in Pregnancy: A Retrospective Analysis from an Urban Maternal Mental Health Centre in New Zealand
General Psychiatry Key Words: lamotrigine, mood stabilisers, bipolar disorder, fetal and maternal outcomes Maternal and Fetal Outcomes After Lamotrigine Use in Pregnancy: A Retrospective Analysis from
More informationRESEARCH. Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study
Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study Lars Henning Pedersen, research assistant, 1 visiting scholar, 2 Tine Brink Henriksen, consultant,
More informationDepression: Part 2. in All the Wrong Places. Treatment of Depression During Pregnancy. What Causes Depression During Pregnancy?
Guest CME: McMaster University Postpartum Title Depression: in All the Wrong Places Part 2 By Pratap Chokka, MD, FRCPC For most women, pregnancy is a time of well-being. For the vulnerable woman, however,
More informationCommentary (DRAFT) Paroxetine, septal defects, and research defects. Platitudes first. Confounding bias and information bias
Paroxetine, septal defects, and research defects Many years ago I was asked to consult a drug company on a possible causal connection between taking some drug and a devastating disease. I believe the case
More informationInformation for Providers on Antidepressants during Pregnancy and Breastfeeding January 2018
Antidepressants Risks in Pregnancy Safety Data: No randomized control trials. Safety data derived largely from cohort studies, registry data, and prescription monitoring registries. Older studies suggested
More informationار ناج هکنآ مان هب تخومآ
فکرت را جان آنکه به نام آموخت صرع در حاملگی بیش از 90 درصد مادران مصروع می توانند فرزندان طبیعی داشته باشند Are antiepileptic drugs necessary? What effect do antiepileptic drugs have on the fetus? What
More informationPharmacologic Considerations in the Pregnant Patient (For the PCP)
Pharmacologic Considerations in the Pregnant Patient (For the PCP) Aspirin Use in Pregnancies At Risk Contemporary Treatment of the A2 Diabetic Statin Exposure in Early Pregnancy Continuation of SSRI Rx
More informationMOOD DISORDERS DURING PREGNANCY AND THE POSTPARTUM
MOOD DISORDERS DURING PREGNANCY AND THE POSTPARTUM Learning Objectives Implement evidence-based strategies to manage mood disorders during pregnancy Improve diagnosis and treatment of mood disorders during
More informationGuidance for Preconception Care of Women with Depression and Anxiety Disorders Posted July 09, 2010
Before, Between & Beyond Pregnancy The National Preconception Curriculum and Resources Guide for Clinicians Guidance for Preconception Care of Women with Depression and Anxiety Disorders Posted July 09,
More informationAngst og depresjon under graviditet og postpartum: et epidemiologisk perspektiv
Angst og depresjon under graviditet og postpartum: et epidemiologisk perspektiv Malin Eberhard-Gran, professor MD, PhD Norwegian Institute of Public Health og Akershus University Hospital Mood and anxiety
More informationProduct Labeling to Communicate Benefits and Risks of Treatment for Opioid Use Disorder in Pregnant Women. Hendrée E. Jones, PhD
1 The National Academies of Sciences, Engineering and Medicine Regulatory Strategies of address prescription opioidrelated harms 4 th of November, 2016 Washington DC Product Labeling to Communicate Benefits
More informationTreating Peri and Postnatal Depression and Anxiety
University of North Dakota UND Scholarly Commons Physician Assistant Scholarly Project Papers Department of Physician Studies 2018 Treating Peri and Postnatal Depression and Anxiety Emily M. Stevenson
More informationSupplementary Online Content
Supplementary Online Content Mølgaard-Nielsen D, Hviid A. Newer-generation antiepileptic drugs and the risk of major birth defects. JAMA. 2011;305(19):1996-2002. emethods. Birth defects and potential confounders
More informationResearch. Bupropion is an aminoketone that is
Research OBSTETRICS Maternal use of bupropion and risk for congenital heart defects Sura Alwan, MSc; Jennita Reefhuis, PhD; Lorenzo D. Botto, MD; Sonja A. Rasmussen, MD, MS; Adolfo Correa, MD, MPH; Jan
More informationMental Health Series for Perinatal Prescribers. Perinatal Depression
Mental Health Series for Perinatal Prescribers Perinatal Depression Perinatal Depression Timing of symptoms Maternal depression is present before or during pregnancy at least 60% of the time DSM-5 and
More informationDr Veenu Gupta MD MRCPsych Consultant, Child Psychiatrist Stockton on Tees, UK
Dr Veenu Gupta MD MRCPsych Consultant, Child Psychiatrist Stockton on Tees, UK Extremely Preterm-EP Very Preterm-VP Preterm-P Late Preterm-LP There is greater improvement of survival at extremely low
More information5/24/ Maria H. Elswick, MD. Maternal Wellness Program Physician Lead
Maria H. Elswick, MD Maternal Wellness Program - Physician Lead Department of Obstetrics & Gynecology Kaiser Permanente San Diego Maria H. Elswick, MD Maternal Wellness Program Physician Lead Department
More informationSupplementary Online Content
Supplementary Online Content Huybrechts KF, Hernández-Díaz S, Patorno E, et al. Antipsychotic use in pregnancy and the risk for congenital malformations. JAMA Psychiatry. Published online August 17, 2016.
More informationMaternal Depression: Prevalence, Implications, Diagnosis, and Current Treatment Options
Maternal Depression: Prevalence, Implications, Diagnosis, and Current Treatment Options Sarah E. (Betsy) Bledsoe-Mansori PhD, MPhil, MSW Assistant Professor Cathy Nguyen UNC School of Social Work Presented
More informationEarly Intervention in Pregnancy
Early Intervention in Pregnancy Dr Lucy Mackillop Obstetric Physician Honorary Senior Clinical Lecturer Women s Centre Oxford University Hospitals NHS Foundation Trust TVSCN conference 17 th January 2017
More informationNEURODEVELOPMENT OF CHILDREN EXPOSED IN UTERO TO ANTIDEPRESSANT DRUGS
NEURODEVELOPMENT OF CHILDREN EXPOSED IN UTERO TO ANTIDEPRESSANT DRUGS ABSTRACT Background Many women of reproductive age have depression, necessitating therapy with either a tricyclic antidepressant drug
More informationWomen s Mental Health
Women s Mental Health Linda S. Mullen, MD Director, Women s Mental Health Assistant Professor of Clinical Psychiatry in OB/GYN Columbia University & NewYork Presbyterian Hospital Departments of Psychiatry
More informationCOMPLICATIONS OF PRE-GESTATIONAL AND GESTATIONAL DIABETES IN SAUDI WOMEN: ANALYSIS FROM RIYADH MOTHER AND BABY COHORT STUDY (RAHMA)
COMPLICATIONS OF PRE-GESTATIONAL AND GESTATIONAL DIABETES IN SAUDI WOMEN: ANALYSIS FROM RIYADH MOTHER AND BABY COHORT STUDY (RAHMA) Prof. Hayfaa Wahabi, King Saud University, Riyadh Saudi Arabia Hayfaa
More informationduring conception, pregnancy and lactation at 2 U.S. medical centers
Use of HIV preexposure prophylaxis during conception, pregnancy and lactation at 2 U.S. medical centers Dominika Seidman, MD Shannon Weber, Maria Teresa Timoney, Karishma Oza, Elizabeth Mullins, Rodney
More informationSummary. HVRA s Cardio Vascular Genetic Detailed L2 Obstetrical Ultrasound. CPT 76811, 76825, _ 90% CHD detection. _ 90% DS detection.
What is the role of fetal echocardiography (2D 76825, cardiovascular color flow mapping 93325) as performed in conjunction with detailed fetal anatomy scan (CPT 76811) now that AIUM requires limited outflow
More informationUse of Selective Serotonin Reuptake Inhibitors During Pregnancy and Risk of Congenital Cardiac Malformations
Pacific University CommonKnowledge School of Physician Assistant Studies Theses, Dissertations and Capstone Projects Summer 8-13-2016 Use of Selective Serotonin Reuptake Inhibitors During Pregnancy and
More informationCNS SPECTRUMS. CME Review Article. Between a Rock-a-bye and a Hard Place: Mood Disorders During the Peripartum Period
CNS SPECTRUMS CME Review Article Between a Rock-a-bye and a Hard Place: Mood Disorders During the Peripartum Period This activity is provided by the Neuroscience Education Institute. Additionally provided
More informationAdvances in Care for Pregnant and Postpartum Women With Mental Illness
F Mental Illness FMF-Toronto November 15, 2018 Advances in Care for Pregnant and Postpartum Women With Mental Illness Simone Vigod, MD, MSc, FRCPC Psychiatry, Women s College Hospital William Watson, MD,
More informationAnnex III. Amendments to relevant sections of the summary of product characteristics and package leaflets
Annex III Amendments to relevant sections of the summary of product characteristics and package leaflets Note: These amendments to the relevant sections of the Summary of Product Characteristics and package
More informationSCREENING FOR ANXIETY IN BC: IS THE EPDS ENOUGH?
SCREENING FOR ANXIETY IN BC: IS THE EPDS ENOUGH? NICHOLE FAIRBROTHER, PH.D. R.PSYCH. ASSISTANT PROFESSOR UBC DEPARTMENT OF PSYCHIATRY ISLAND MEDICAL PROGRAM TEAM & FUNDING TEAM FUNDING Nichole Fairbrother
More information%, # Southern Medical Association July / 01/ /7 23 #, 2 3
Southern Medical Association July 2011 Robert A. Bashford, M.D., Professor Associate Dean for Admissions University of North Carolina Professor of Psychiatry and OB-GYN!" #! $ %&'(%&) $ * &+ %&, ' ) #
More informationSafe Babies Foster Parent Training Program
Safe Babies Foster Parent Training Program Module 1: Introduction to the Safe Babies Program 1 Begin the process of group participation Learning outcomes Understand the purpose and origins of the Safe
More informationThe Safety of Asthma and Allergy Medications in Pregnancy: New Horizons
The Safety of Asthma and Allergy Medications in Pregnancy: New Horizons Jennifer Namazy, MD Division of Allergy Scripps Clinic, San Diego Michael Schatz, MD, MS Department of Allergy Kaiser Permanente,
More informationCurrents: Dr. Cohen, are benzodiazepines teratogenic?
Update on Reproductive Safety of Psychotropic Medications Part II of an Interview with Lee S. Cohen, M.D. (Dr. Cohen is Director, Perinatal and Reproductive Psychiatry Clinical Research Program, and Associate
More informationAutism spectrum disorder in under 19s: recognition, referral and diagnosis
1 National Institute for Health and Care Excellence Final Autism spectrum disorder in under 19s: recognition, referral and diagnosis [A] Evidence review for factors and neurodevelopmental disorders that
More informationDepression, anxiety, and obesity
Depression, anxiety, and obesity 5As Team Learning modules Depression and anxiety are two prevalent mood disorders that affect Canadians, with as many as 40-70% of overweight/obese individuals at high
More informationDiagnosis of Congenital Cardiac Defects Between 11 and 14 Weeks Gestation in High-Risk Patients
Article Diagnosis of Congenital Cardiac Defects Between 11 and 14 Weeks Gestation in High-Risk Patients Zeev Weiner, MD, Abraham Lorber, MD, Eliezer Shalev, MD Objective. To examine the feasibility of
More informationPSYCHIATRIC COMPLICATIONS OF PREGNANCY REX GENTRY, MD
PSYCHIATRIC COMPLICATIONS OF PREGNANCY REX GENTRY, MD OVERVIEW MISINFORMATION FROM DOCTORS BUY A DRESS, YOU LL FEEL BETTER MUCH NEEDS TO BE LEARNED YET MUCH IS NOW KNOWN COMMON YET GENERALLY UNTTREATED
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Rough K, Seage GR III, Williams PL, et al. Birth outcomes for
More informationSurveillance report Published: 9 January 2017 nice.org.uk
Surveillance report 2017 Caesarean section (2011) NICE guideline CG132 Surveillance report Published: 9 January 2017 nice.org.uk NICE 2017. All rights reserved. Contents Surveillance decision... 3 Reason
More informationParental antibiotics and childhood asthma : a population-based study. Örtqvist, A.K.; Lundholma, C.; Fang, F.; Fall, T.; Almqvist, C.
This is an author produced version of a paper accepted by Journal of Allergy and Clinical Immunology. This paper has been peer-reviewed but does not include the final publisher proof-corrections or journal
More informationCurrents: Journal of Affective Disorders Cohen: Currents: Cohen: not Currents: Cohen:
Update on Reproductive Safety of Psychotropic Medications Part I of an Interview with Lee S. Cohen, M.D. (Dr. Cohen is Director, Perinatal and Reproductive Psychiatry Clinical Research Program, and Associate
More informationEffect of Various Degrees of Maternal Hyperglycemia on Fetal Outcome
ORIGINAL ARTICLE Effect of Various Degrees of Maternal Hyperglycemia on Fetal Outcome ABSTRACT Shagufta Tahir, Shaheen Zafar, Savita Thontia Objective Study design Place & Duration of study Methodology
More informationMarijuana in the Obstetric Population
Marijuana in the Obstetric Population Brittany MacGregor PGY 1 on behalf of Sophia Lenson PGY 3, Queens OB/Gyn Objectives 1. Review the status of legalization of cannabis products in Canada and the potential
More informationPromoting Maternal Mental Health During and After Pregnancy
Promoting Maternal Mental Health During and After Pregnancy Leena Mittal, MD, FAPM Associate Medical Director, MCPAP for Moms Director, Reproductive Psychiatry Consultation, Brigham and Women s Hospital
More informationMARIJUANA USE AMONG PREGNANT AND POSTPARTUM WOMEN
MARIJUANA USE AMONG PREGNANT AND POSTPARTUM WOMEN Symposium on Marijuana Research in Washington May 18, 2018 THERESE GRANT, PH.D. PROFESSOR, DEPARTMENT OF PSYCHIATRY & BEHAVIORAL SCIENCES UNIVERSITY OF
More informationThe risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis
British Journal of Clinical Pharmacology DOI:10.1111/bcp.12849 The risk of major cardiac associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis Anick
More informationUse of psychotropic drugs during pregnancy and breast-feeding
Acta Psychiatr Scand 2015: 132 (Suppl. 445): 1 28 All rights reserved DOI: 10.1111/acps.12479 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd ACTA PSYCHIATRICA SCANDINAVICA Clinical overview
More informationPerinatal Mood and Anxiety Disorders Cort A. Pedersen, M.D. UNC Department of Psychiatry
Perinatal Mood and Anxiety Disorders Cort A. Pedersen, M.D. UNC Department of Psychiatry Prevalence of Perinatal Depressive and Anxiety Disorders Depression: approximately 14% within the first 2-3 months
More informationUse of Selective Serotonin Reuptake Inhibitors during Pregnancy and Risk of Autism
The new england journal of medicine original article Use of Selective Serotonin Reuptake Inhibitors during Pregnancy and Risk of Autism Anders Hviid, Dr.Med.Sci., Mads Melbye, M.D., Dr.Med.Sci., and Björn
More informationProject TEACH Addressing Tobacco Treatment for Pregnant Women Jan Blalock, Ph.D.
Project TEACH Addressing Tobacco Treatment for Pregnant Women Jan Blalock, Ph.D. Prevalence of Smoking and Cessation During Pregnancy In 2014, 14% in women with Medicaid coverage versus 3.6% of women with
More informationSupplementary Online Content
Supplementary Online Content Sandin S, Nygren K-G, Iliadou A, Hultman C, Reichenberg. Autism and Mental Retardation Among Offspring Born After In Vitro Fertilization. JAMA. doi:10.1001/jama.2013.7222.
More informationSurveillance report Published: 8 June 2017 nice.org.uk. NICE All rights reserved.
Surveillance report 2017 Antenatal and postnatal mental health: clinical management and service guidance (2014) NICE guideline CG192 Surveillance report Published: 8 June 2017 nice.org.uk NICE 2017. All
More informationShould we treat hepatitis B positive pregnant women to prevent mother to child transmission?
Should we treat hepatitis B positive pregnant women to prevent mother to child transmission? Daniel Shouval Liver Unit Hadassah-Hebrew University Hospital Jerusalem, Israel VHPB Vienna June 1-2, 2017 Background
More informationTo clarify this issue, we have made the following changes to the Introduction and Discussion:
Manuscript ID BMJ.2017.038618 "Risk of Neonatal Drug Withdrawal after Intrauterine Co-Exposure to Opioids and Psychotropic Medications: A Cohort Study" Please find below our replies to the comments made
More informationCase 2:12-md CMR Document 979 Filed 06/27/14 Page 1 of 24 IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA
Case 2:12-md-02342-CMR Document 979 Filed 06/27/14 Page 1 of 24 IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA : IN RE: ZOLOFT (SERTRALINE : MDL No. 2342 HYDROCLORIDE) PRODUCTS
More informationThe Ever-Changing Approaches to Diabetes in Pregnancy
The Ever-Changing Approaches to Diabetes in Pregnancy Kirsten E. Salmeen, MD Assistant Professor Obstetrics, Gynecology & Reproductive Sciences Maternal-Fetal Medicine I have nothing to disclose. Approaches
More informationVirtual Mentor American Medical Association Journal of Ethics September 2013, Volume 15, Number 9:
Virtual Mentor American Medical Association Journal of Ethics September 2013, Volume 15, Number 9: 746-752. ETHICS CASE Weighing Risks and Benefits of Prescribing Antidepressants during Pregnancy Commentary
More informationMental Health and Women s Health
Disclosure information I have nothing to disclose. Mental Health and Women s Health Ellen Haller, M.D. Professor of Clinical UCSF Department of Learning Objectives Know what to do when a pt c/o PMS/PMDD
More informationMarijuana During Pregnancy: An Overview
Marijuana During Pregnancy: An Overview Marijuana: Epidemiology Marijuana is the most commonly used illicit drug and, after alcohol and tobacco, the most commonly used drug during pregnancy (1) 48-60%
More informationBRAIN STIMULATION AN ALTERNATIVE TO DRUG THERAPY IN MATERNAL DEPRESSION?
BRAIN STIMULATION AN ALTERNATIVE TO DRUG THERAPY IN MATERNAL DEPRESSION? Kira Stein, MD Medical Director West Coast Life Center Sherman Oaks, California CA Maternal Mental Health Initiative - 2013 2013
More informationPERINATAL TOBACCO USE
PERINATAL TOBACCO USE Child Fatality Task Force Meeting December 7, 2015 Erin McClain, MA, MPH You Quit, Two Quit, UNC Center for Maternal & Infant Health Percentage Women & Tobacco Use in NC 2 50 45 40
More informationEpatite B: fertilità, gravidanza ed allattamento, aspetti clinici e terapeutici. Ivana Maida
Epatite B: fertilità, gravidanza ed allattamento, aspetti clinici e terapeutici Ivana Maida Positivity for HBsAg was found in 0.5% of tested women In the 70s and 80s, Italy was one of the European countries
More informationThe data were analysed using Fisher s exact test and the chi-squared test.
Congenital malformations are a major cause of perinatal and neonatal death [1], both in developed and developing countries [2]. These malformations have multifactorial etiologies and 40% of cases are idiopathic
More informationEffects of Prenatal Illicit Drug. Use on Infant and Child
Effects of Prenatal Illicit Drug Use on Infant and Child Development Andrew Hsi, MD, MPH Larry Leeman, MD, MPH Family Medicine MCH Grand Rounds 6 July 2011 Objectives for Presentation At the end of this
More informationDepression in Pregnancy and the Postpartum Period
Depression in Pregnancy and the Postpartum Period Sarah Gopman, MD Assistant Professor Maternal and Child Health Grand Rounds Dept. of Family and Community Medicine University of New Mexico April 4, 2012
More informationOriginal Article. Associated Anomalies and Clinical Outcomes in Infants with Omphalocele: A Single-centre 10-year Review
HK J Paediatr (new series) 2018;23:220-224 Original Article Associated Anomalies and Clinical Outcomes in Infants with Omphalocele: A Single-centre 10-year Review YY CHEE, MSC WONG, RMS WONG, KY WONG,
More informationAssessment and Management of Depression Over the Female Life Cycle
Assessment and Management of Depression Over the Female Life Cycle Stephen A. Young, MD Regional Medical Officer/Psychiatry US Department of State, American Embassy, Tokyo Office of Personnel Management
More informationPregnancy and Epilepsy
Pregnancy and Epilepsy Nowhere is the problem more evident or more complicated than in pregnancy. In the United States, epilepsy affects nearly one million women of childbearing potential. Alarm bells
More informationMaternal Mental Health: Risk Factors, Ramifications, and Roles. Anna Glezer MD UCSF Assistant Clinical Professor Founder, Mind Body Pregnancy
Maternal Mental Health: Risk Factors, Ramifications, and Roles Anna Glezer MD UCSF Assistant Clinical Professor Founder, Mind Body Pregnancy Disclosures None Objectives for Today Review major maternal
More information